Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corbus Pharma (CRBP)

Corbus Pharma (CRBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Corbus Pharma 500 River Ridge Drive Norwood MA 02062 USA

P: 617-963-0100

Description:

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Key Statistics

Overview:

Market Capitalization, $K 130,240
Shares Outstanding, K 125,231
Annual Sales, $ 3,940 K
Annual Net Income, $ -111,270 K
Last Quarter Sales, $ 140 K
Last Quarter Net Income, $ -17,140 K
60-Month Beta 1.81
% of Insider Shareholders 8.20%
% of Institutional Shareholders 39.69%
Float, K 114,962
% Float 91.80%

Growth:

1-Year Return -32.47%
3-Year Return -86.23%
5-Year Return -84.68%
5-Year Revenue Growth 506.15%
5-Year Earnings Growth -407.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.82
EPS Growth vs. Prev Qtr -7.14%
EPS Growth vs. Prev Year 71.15%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -9.20
Price/Earnings to Growth N/A
Return-on-Equity % -126.28%
Return-on-Assets % -66.87%
Profit Margin % -2,824.11
Net Margin % N/A
Debt/Equity 0.20
Price/Sales 34.99
Price/Cash Flow N/A
Price/Book 2.03
Book Value/Share 0.62
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar